Study group | Study population (N) | Overall Bartonella spp prevalence N (%) | BAPGM diagnostic platform | Overall molecular prevalence of other CVBD pathogens N (%) | Hemotropic Mycoplasma 16S PCR | Ehrlichia/Anaplasma spp PCR | SFG Rickettsia PCR | Babesia spp PCR | ||
---|---|---|---|---|---|---|---|---|---|---|
 |  |  | Pre-enrichment PCR | Post-enrichment PCR | Isolate |  |  |  |  |  |
Group I | 47 | 9 (19%) | Bk (3) | Bh SA2 (2) | 0 | 3 (6%) | Mhc (3) | 0 | 0 | 0 |
Bh HI (1) | B spp. (2) | |||||||||
B spp. (1) | ||||||||||
Group II | 50 | 10 (20%) | Bvb III (1) | Bvb II (1) | Bvb II (8) | 3 (6%) | Mhc (1) | E. ewingii (2) | 0 | 0 |
Group III | 21 | 2 (10%) | Bvb I (1)†| Bvb I (1)* | Bvb I (1)* | 4 (19%) | Mhc (1) | E. ewingii (2) | 0 | 0 |
 |  |  | Bvb I (1)* |  |  |  | C Mhp (1) |  |  |  |